A medication name is a starting point for evaluating a weight-management practice, not the conclusion. Pettersen Lifestyle Medicine lists semaglutide and tirzepatide among its prescription options and describes a broader service involving medical assessment, nutrition, activity guidance and ongoing monitoring. That establishes a documented weight-care offering. It does not establish which products the practice prescribes, how they reach patients or whether results from studies of specific medicines apply to its service. Those distinctions are central to this documentary review.
The practice advertises a Lockeford, California, address and a membership-based internal medicine model, with weight management also available separately. Public pages consulted October 19, 2026, provide meaningful information about the proposed care relationship but leave substantial practical details unresolved. This review separates provider statements from independently established clinical context. As our guide to what public provider documents can prove explains, a description of services can document an offering without verifying credentials, demonstrating patient outcomes or establishing the quality of every step in treatment.
At a glance
- Documented medication options
- The weight-management page names semaglutide, tirzepatide and phentermine, but does not identify brands, formulations or administration routes.Sources: [7]
- Two enrollment arrangements
- Weight management is advertised as a standalone service and as included within internal medicine membership; the difference in scope is not explained.
- Assessment and monitoring
- The advertised process includes a medical evaluation, body composition analysis, health-history review and adjustments based on progress and laboratory results.Sources: [7]
- Payment and insurance boundaries
- No membership or medication prices were found in the consulted documentation. Weight-loss services are described as outside traditional insurance, while laboratory work is described as an additional cost covered by insurance without plan-specific confirmation.
- Cancellation limitation
- The general FAQ says patients can cancel by notifying the practice, but the first three subscription months are nonrefundable; later refund calculations and applicability to each service arrangement are not specified.Sources: [9]
What the practice actually documents
Pettersen Lifestyle Medicine is presented as a membership-based internal medicine practice rather than a medication-only subscription company. Its privacy policy identifies the business as Gabriel Raw Pettersen, MD Inc., doing business as Pettersen Lifestyle Medicine. The practice says its model emphasizes wellness, prevention, longer visits, open communication and proactive planning. It also says it limits its patient population to allow more individual attention. These are descriptions of the intended service model, not independently measured evidence of appointment availability or care quality.
Gabriel Pettersen states that he graduated from St. George’s Medical School, completed internal medicine residency at Drew/UCLA in 2005 and has been a board-certified internal medicine physician for 20 years. Separately, the weight-management page says patients work directly with a physician who completed fellowship training in obesity medicine. These are provider-reported credentials and training claims. This review did not independently verify a license, certification, fellowship or the operational details of direct physician access.
The broader membership includes routine medical examinations and Dr. Pettersen’s gastrointestinal support services. The FAQ encourages patients to schedule as many appointments as necessary for proactive health care, while excluding management of chronic pain with narcotics. These details help define the actual business: a broader medical relationship with weight care among its offerings. They should not automatically be read as benefits of the standalone weight service, whose complete scope is not separately itemized.
The medication list stops short of identifying a product
The weight-management page lists appetite suppressants such as phentermine, GLP-1 medications such as semaglutide and tirzepatide, and unspecified oral medications described as “fat-burning.” That last phrase is the provider’s description, not an identified medicine or an independently established benefit. Naming semaglutide and tirzepatide confirms that the practice markets medication-supported weight care. It does not identify a brand, formulation, route, presentation, dispensing pharmacy or whether the offered product would be FDA approved or compounded.
Those missing details materially limit an evidence review. FDA approval belongs to a particular drug product, not to a clinic or pharmacy. Compounded preparations are not FDA approved and do not undergo FDA premarket review for safety, effectiveness and quality. That distinction alone does not demonstrate clinical inequivalence or establish that this practice uses compounded drugs. FDA recommends compounded drugs when an individual’s medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy.
Before connecting a treatment proposal to published research, patients need the exact product identity and administration route. Our explanation of approved medicines and compounded preparations separates these evidence questions without treating an ingredient name as sufficient documentation. Pettersen’s public pages do not establish a dispensing or shipping process, stock availability, delivery charges or arrival times. They also do not provide a basis for attributing any particular compounding practice, ingredient salt or pharmacy relationship to the clinic.
What the advertised assessment and follow-up include
The initial weight consultation is described with more specificity than the medication supply arrangements. The practice lists a comprehensive medical evaluation, body composition analysis, laboratory work and a metabolic panel, plus review of medical history and weight-loss goals. This documents several components of an intended assessment. It does not establish how long the first appointment lasts, which tests every patient receives, how soon an appointment is available or whether all components can be completed remotely.
Ongoing care includes routine medical examinations, a customized physician-supervised plan, monitoring and adjustments based on progress and laboratory results. The program also advertises nutritional education, behavioral support, habit guidance, tracking and accountability. Exercise recommendations, activity tracking and motivation appear as additional elements. These are substantive offerings beyond prescription access, although the pages do not specify session frequency, the professionals delivering each component or how progress is recorded and reviewed with the patient.
This is where the service description aligns with an important clinical principle without proving its execution. NIDDK describes weight-management medication as accompanying healthy eating and physical activity, with follow-up addressing response and tolerability. Pettersen documents a plan to provide those surrounding services, but not a fixed review schedule or a medication-specific escalation process. Our guide to clinical follow-up beyond renewal notices explains why asking who reviews symptoms and results is more informative than simply asking whether follow-up is included.
Clinical research is not a performance report for this practice
The provider says treatment plans are individualized and medically supervised to support safe, sustainable results. That is a commercial description of its approach, not a published outcome finding. The consulted pages do not supply a defined patient cohort, follow-up duration, average weight change, discontinuation rate or adverse-event denominator for Pettersen’s program. Consequently, this review cannot determine how its patients fare, compare its effectiveness with another practice or verify sustained results after treatment ends.
Published studies answer narrower questions about the products, populations and treatment conditions they actually investigated. Results cannot simply be transferred to a practice because it lists the same ingredient name. They also do not establish outcomes for unspecified compounded preparations, different routes, microdoses or an individual patient. The distinction explained in why trials are not company performance reports is particularly important here because Pettersen’s public medication descriptions do not identify the product needed to make a careful research comparison.
NIDDK also emphasizes that medication selection involves benefits, side effects, health conditions, other medicines, family history and costs. Treatment duration depends on response and side effects, and obesity may require long-term care. Those principles support asking the practice how it evaluates treatment over time; they do not establish this provider’s eligibility rules or justify a promise of lasting weight loss. The public record supports a description of intended care, not a provider-specific efficacy conclusion.
Two enrollment paths, with the financial comparison unresolved
The weight-management page says its services are offered independently of the internal medicine membership. The general FAQ also says internal medicine includes medical weight management and allows patients to subscribe to weight care alone. These statements can describe two coexisting choices rather than a contradiction. What is missing is a clear comparison: whether both arrangements include the same assessments, communication access, follow-up frequency and prescribing services, and what either arrangement costs.
The FAQ identifies quarterly, semiannual and annual payment options in its internal medicine membership section. Those intervals should not be assigned to the standalone weight service without confirmation. No dollar prices, introductory charges, medication costs or prepaid discounts appear in the consulted documentation. Nor does the published payment schedule establish a particular supply quantity, price guarantee or minimum treatment commitment. A written proposal is needed to distinguish the cost of medical services from medication, laboratory and any delivery expenses.
The following questions connect documented features to the missing information most likely to affect an enrollment decision. They are not assumptions that each listed item carries a separate fee. The practice also claims fees may qualify for HSA, FSA, HRA or MSA funding and directs patients to their tax expert or plan coordinator. That statement is not verification that a particular expense qualifies under an individual account or plan.
| Topic | Public documentation | Useful confirmation |
|---|---|---|
| Service arrangement | Standalone weight care and membership inclusion are advertised. | Which visits and communication benefits belong to each option? |
| Payment intervals | Internal medicine lists quarterly, semiannual or annual payment. | What is collected initially, and what applies to standalone care? |
| Medication | Several prescription options are named. | What exact product is proposed, and who bills for it? |
| Laboratories | An additional cost is described as covered by insurance. | Which laboratory, tests and plan benefits apply? |
| Cancellation | The first three subscription months are nonrefundable. | Which agreement applies, and how are later refunds calculated? |
Insurance statements need to be read service by service
The weight-management page states that its weight-loss services are not covered by traditional health insurance. The general FAQ goes further for cash services: it says those fees are entirely outside plan coverage and may not be submitted to a public or private plan for reimbursement. These statements are important financial boundaries. A patient should not assume that a receipt for the membership or standalone service can be submitted for reimbursement simply because the practice also discusses insurance participation elsewhere.
Laboratory work is presented differently. The weight page calls laboratory testing and the metabolic panel an additional cost “covered by your insurance,” but does not name insurers, laboratories, coverage conditions or potential patient responsibility. That wording does not verify benefits for an individual plan. Similarly, the physician says he remains in-network and Medicare-participating for services requiring coverage, while encouraging members to maintain insurance for major medical events. This does not make the membership or weight service an insured benefit.
The FAQ welcomes Medicare beneficiaries while saying the model operates outside what Medicare covers. It also says the practice accepts patients without limits on preexisting conditions. General acceptance into a practice is not a guarantee of a particular prescription or a waiver of medication-specific assessment. NIDDK notes that medication coverage varies by plan; patients therefore need separate answers about service fees, laboratory benefits and the proposed medicine rather than one broad assurance that the practice accepts insurance.
Access is described more clearly than geography or dispensing
The published office address is 14092 E. Hwy 88, Lockeford, CA 95237. Contact options include telephone at (209) 804-5630, fax at (209) 582-0844 and email at info@pettersenlifestylemedicine.com. The membership FAQ advertises communication with the physician through text, telephone, video and email. It identifies Hint Health as a platform partner for messaging and video, with the stated goal of delivering care in an appropriate format. These are documented contact paths, not published response-time commitments.
An office in California and an offer of telemedicine do not establish where patients can receive clinical care. The consulted documentation does not provide a state-by-state service area, clinical age minimum, medication-specific eligibility criteria, language services or support hours. It also does not explain which visits require in-person attendance. Prospective patients outside the immediate area should confirm whether the practice can treat them where they are physically located, and how any examinations or testing would be arranged.
The medication handoff remains undocumented: no dispensing pharmacy, shipping arrangement or delivery timetable is identified. That absence is not evidence that these services do not exist, but it prevents a review of their responsibilities. If an injectable GLP-1 medicine is shipped, FDA explicitly advises not using a product that arrives warm or with insufficient refrigeration and contacting the provider or dispensing pharmacy. This is general regulatory guidance, not a finding about deliveries from Pettersen Lifestyle Medicine.
Cancellation, records and the limits of the public agreement
The general FAQ says cancellation is straightforward: notify the practice. It also states that the first three months of a subscription are nonrefundable and that a cancellation request and refund will be processed accordingly. The page does not publish a later-refund formula, processing deadline, automatic-renewal terms or required cancellation notice. It is also unclear how this wording applies to each enrollment arrangement. The nonrefundable period should not be converted into an undocumented minimum commitment or an assurance that later payments will be refunded.
The privacy policy says the business does not sell personal, health or sensitive information to third parties for their business purposes, and describes sharing as permitted by law, its policy or consent. It also describes possible rights to access and update records, obtain copies and make privacy complaints, depending on applicable law. These are relevant documentary commitments, but this review did not test record access, messaging security, privacy practices or how a departing patient’s care would be transferred.
One policy detail merits clarification: the privacy document identifies Pettersen Lifestyle Medicine but also mentions a different website address and references MDVIP. The consulted material does not explain those references or establish an MDVIP relationship. Separately, the website terms state that online content is informational and does not substitute for personal medical care. Taken together, these documents are useful preparation for a conversation, but they are not a complete, individualized service agreement or treatment plan.
Questions & answers
Does Pettersen Lifestyle Medicine actually advertise GLP-1 weight treatment?
Yes. Its weight-management page explicitly names semaglutide and tirzepatide among prescription options. It also lists phentermine and unspecified oral medications. That confirms an advertised medication-supported weight service, not access to a guaranteed prescription. The public documentation does not identify the specific brands, formulations, routes or pharmacies involved, so patients need those details before assessing the proposed product.
Must I join the internal medicine membership to receive weight care?
The public pages say no: weight management is available as a standalone service. The general FAQ also says it is included in internal medicine membership. What remains unclear is whether the two options provide identical visits, monitoring and communication access. Ask for a written comparison of included services and total charges rather than assuming that membership and standalone care are interchangeable.
How much will the first payment and ongoing treatment cost?
The consulted pages do not publish dollar amounts for either enrollment option or for medication. Internal medicine membership can be paid quarterly, semiannually or annually, but standalone billing intervals are not specified. Laboratory testing is described as an additional cost. Request an itemized first-payment quote and an ongoing schedule showing service fees, medication, testing and any delivery charges separately.
Can Medicare beneficiaries or people with existing conditions enroll?
The general FAQ welcomes Medicare beneficiaries and says it accepts patients without limits on preexisting conditions. It also says the care model is outside Medicare coverage. These are enrollment statements, not confirmation that a particular medicine is appropriate or covered. Medication-specific eligibility and any clinical restrictions need to be established through the practice’s assessment rather than inferred from its general acceptance policy.
Does telemedicine mean I can use the practice from any state?
No nationwide clinical coverage is established by the consulted documentation. The practice advertises a Lockeford office and telemedicine through Hint Health, but does not list the states where it treats patients. Contact the office to confirm geographic eligibility, whether an initial in-person visit is required and where body composition assessment or laboratory testing would occur before paying to enroll.
If I cancel, will unused subscription payments be returned?
The FAQ makes the first three subscription months nonrefundable. It says patients can cancel by notifying the practice and refers to processing a refund accordingly, but supplies no formula for later refunds or processing timetable. Cancellation therefore should not be read as a full-refund promise. Confirm the applicable agreement, effective cancellation date and treatment of unused payments for the specific service you choose.
Our assessment
Pettersen Lifestyle Medicine documents more than prescription access: its advertised service includes physician-led assessment, body composition analysis, laboratory review, lifestyle support and ongoing adjustment. It also offers a potentially meaningful choice between standalone weight care and a broader internal medicine relationship. Those are concrete features of the public offering, although the training, access and service-quality statements remain provider claims rather than independently verified findings. The principal evidence limitation is the gap between naming medicines and documenting the actual treatment product. Without product identity, pharmacy arrangements, prices, geographic coverage and clear service-specific terms, the public record cannot support a provider efficacy judgment or a reliable all-in cost comparison. A useful next step is an itemized written proposal identifying the medicine, responsible pharmacy, monitoring schedule, included services and cancellation terms. That would allow a prospective patient to evaluate this particular care arrangement rather than relying on the reputation of an ingredient or the appeal of a membership model.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.
- FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
- NIDDK: prescription medications for overweight and obesity ↗
- Wilding et al. (2021): STEP 1 semaglutide trial ↗
- Jastreboff et al. (2022): SURMOUNT-1 tirzepatide trial ↗
- Pettersen Lifestyle Medicine — about ↗
- Pettersen Lifestyle Medicine — terms of use ↗
- Pettersen Lifestyle Medicine — weight loss care ↗
- Pettersen Lifestyle Medicine — contact ↗
- Pettersen Lifestyle Medicine — faq ↗
- Pettersen Lifestyle Medicine — privacy statement ↗
- Pettersen Lifestyle Medicine — official website ↗